Showing results (11-20 of 123) with videos related to
Sort By:
Pageof 13
Antiviral Research|June 22, 2002
Goals and milestones during treatment of HIV-1 infection with antiretroviral therapy: a pathogenesis-based perspectiveMichael Louie, Martin MarkowitzJournal of Acquired Immune Deficiency Syndromes (1999)|July 23, 2008
In vitro characterization of multidrug-resistant HIV-1 isolates from a recently infected patient associated with dual tropism and rapid disease progressionHiroshi Mohri, Martin MarkowitzCurrent Opinion in HIV and AIDS|October 29, 2019
Islatravir for the treatment and prevention of infection with the human immunodeficiency virus type 1Martin Markowitz, Jay A GroblerDrugs|February 16, 2013
Next-generation integrase inhibitors : where to after raltegravir?Sharon L Karmon, Martin MarkowitzExpert Opinion on Investigational Drugs|March 7, 2008
Raltegravir: an integrase inhibitor for HIV-1Teresa H Evering, Martin MarkowitzDrugs of Today (Barcelona, Spain : 1998)|January 5, 2008
Raltegravir (MK-0518): an integrase inhibitor for the treatment of HIV-1Teresa Hope Evering, Martin MarkowitzCurrent Opinion in HIV and AIDS|April 27, 2018
4'-Ethynyl-2-fluoro-2'-deoxyadenosine, MK-8591: a novel HIV-1 reverse transcriptase translocation inhibitorMartin Markowitz, Stefan G SarafianosExpert Opinion on Investigational Drugs|April 11, 2018
Cabotegravir in the treatment and prevention of Human Immunodeficiency Virus-1Tristan D McPherson, Magdalena E Sobieszczyk, Martin MarkowitzThe Journal of Allergy and Clinical Immunology|August 9, 2005
The gastrointestinal tract is critical to the pathogenesis of acute HIV-1 infectionSaurabh Mehandru, Klara Tenner-Racz, Paul Racz, et al.Journal of Virology|February 5, 2016
Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected MacaquesManxue Jia, Hong Lu, Martin Markowitz, et al.Pageof 13